Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms

Detalhes bibliográficos
Autor(a) principal: Costa,Rui M
Data de Publicação: 2014
Outros Autores: Vazquez-Martul,Eduardo, Reboredo-Mosquera,Juan, Rivera,Constantino
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300005
Resumo: Aim: Comparison between transplant glomerulopathy (TG) and de novo thrombotic microangiopathy (TMA) in renal allograft biopsies in a 10 -year retrospective analysis. Results: Out of a total of 627 biopsies, TG (6.2%) was diagnosed at a later stage (6.9 ± 5.9 vs. 3.5 ± 6.5 years, p = 0.01) and presented higher proteinuria (4.0 ± 3.6 vs. 2.3 ± 1.6 gr/24h, p = 0.02), advanced glomerulosclerosis, interstitial fibrosis/tubular atrophy and interstitial plasma cells (30.8% vs. 0%, p = 0.02). De novo TMA (2.2%) was associated to worse graft disfunction (sCr 4.9 ± 1.8 vs. 2.7 ± 0.2mg/dl, p < 0.01), older donors (53 ± 10 vs. 41 ± 17 years, p = 0.04), PRA levels ≥ 25% (16.7% vs. 3.1%, p = 0.07) and previous rejection events (21.4% vs. 5.3%, p = 0.08). Diffuse glomerular lesions were observed in all TMA cases, with capillary congestion (100 vs. 35.1%, p < 0.01), microthrombi (50% vs. 5.4, p = 0.01), schistocytes (42.8% vs. 7.7%, p = 0.01) and mesangiolysis (85.7% vs. 29.7%, p < 0.01). Positive C4d in de novo TMA cases was similar to TG (71.4% vs. 53.8%, p = ns) but presented arteriolar C4d deposition (35.7 % vs. 8.7%, p = 0.042). Donor -specific antibodies detection was equally found (TG: 41.6%; TMA: 57.1%, p = ns), mainly anti-HLA Class II. In ultrastructural analysis only TG cases presented glomerular basement membrane (GBM) multilayering. Graft loss was similar, but de novo MAT cases had worst first year survival (73.3% vs. 97%, p = 0.013). Conclusion: Both pathologies belong within the spectrum of microcirculatory injury: TG results from subclinical lesion, presenting chronic cyclic accommodation, de novo TMA represents severe form of lytic endothelial lesion
id RCAP_9206cb95471c34963088f2c49388608c
oai_identifier_str oai:scielo:S0872-01692014000300005
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanismsAntibody-mediated rejectionkidney transplantthrombotic microangiopathytransplant glomerulopathyAim: Comparison between transplant glomerulopathy (TG) and de novo thrombotic microangiopathy (TMA) in renal allograft biopsies in a 10 -year retrospective analysis. Results: Out of a total of 627 biopsies, TG (6.2%) was diagnosed at a later stage (6.9 ± 5.9 vs. 3.5 ± 6.5 years, p = 0.01) and presented higher proteinuria (4.0 ± 3.6 vs. 2.3 ± 1.6 gr/24h, p = 0.02), advanced glomerulosclerosis, interstitial fibrosis/tubular atrophy and interstitial plasma cells (30.8% vs. 0%, p = 0.02). De novo TMA (2.2%) was associated to worse graft disfunction (sCr 4.9 ± 1.8 vs. 2.7 ± 0.2mg/dl, p < 0.01), older donors (53 ± 10 vs. 41 ± 17 years, p = 0.04), PRA levels ≥ 25% (16.7% vs. 3.1%, p = 0.07) and previous rejection events (21.4% vs. 5.3%, p = 0.08). Diffuse glomerular lesions were observed in all TMA cases, with capillary congestion (100 vs. 35.1%, p < 0.01), microthrombi (50% vs. 5.4, p = 0.01), schistocytes (42.8% vs. 7.7%, p = 0.01) and mesangiolysis (85.7% vs. 29.7%, p < 0.01). Positive C4d in de novo TMA cases was similar to TG (71.4% vs. 53.8%, p = ns) but presented arteriolar C4d deposition (35.7 % vs. 8.7%, p = 0.042). Donor -specific antibodies detection was equally found (TG: 41.6%; TMA: 57.1%, p = ns), mainly anti-HLA Class II. In ultrastructural analysis only TG cases presented glomerular basement membrane (GBM) multilayering. Graft loss was similar, but de novo MAT cases had worst first year survival (73.3% vs. 97%, p = 0.013). Conclusion: Both pathologies belong within the spectrum of microcirculatory injury: TG results from subclinical lesion, presenting chronic cyclic accommodation, de novo TMA represents severe form of lytic endothelial lesionSociedade Portuguesa de Nefrologia2014-09-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300005Portuguese Journal of Nephrology &amp; Hypertension v.28 n.3 2014reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPenghttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300005Costa,Rui MVazquez-Martul,EduardoReboredo-Mosquera,JuanRivera,Constantinoinfo:eu-repo/semantics/openAccess2024-02-06T17:04:45Zoai:scielo:S0872-01692014000300005Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T02:18:52.894362Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
title Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
spellingShingle Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
Costa,Rui M
Antibody-mediated rejection
kidney transplant
thrombotic microangiopathy
transplant glomerulopathy
title_short Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
title_full Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
title_fullStr Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
title_full_unstemmed Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
title_sort Transplant glomerulopathy and post-transplant de novo thrombotic microangiopathy: common features and pathologic mechanisms
author Costa,Rui M
author_facet Costa,Rui M
Vazquez-Martul,Eduardo
Reboredo-Mosquera,Juan
Rivera,Constantino
author_role author
author2 Vazquez-Martul,Eduardo
Reboredo-Mosquera,Juan
Rivera,Constantino
author2_role author
author
author
dc.contributor.author.fl_str_mv Costa,Rui M
Vazquez-Martul,Eduardo
Reboredo-Mosquera,Juan
Rivera,Constantino
dc.subject.por.fl_str_mv Antibody-mediated rejection
kidney transplant
thrombotic microangiopathy
transplant glomerulopathy
topic Antibody-mediated rejection
kidney transplant
thrombotic microangiopathy
transplant glomerulopathy
description Aim: Comparison between transplant glomerulopathy (TG) and de novo thrombotic microangiopathy (TMA) in renal allograft biopsies in a 10 -year retrospective analysis. Results: Out of a total of 627 biopsies, TG (6.2%) was diagnosed at a later stage (6.9 ± 5.9 vs. 3.5 ± 6.5 years, p = 0.01) and presented higher proteinuria (4.0 ± 3.6 vs. 2.3 ± 1.6 gr/24h, p = 0.02), advanced glomerulosclerosis, interstitial fibrosis/tubular atrophy and interstitial plasma cells (30.8% vs. 0%, p = 0.02). De novo TMA (2.2%) was associated to worse graft disfunction (sCr 4.9 ± 1.8 vs. 2.7 ± 0.2mg/dl, p < 0.01), older donors (53 ± 10 vs. 41 ± 17 years, p = 0.04), PRA levels ≥ 25% (16.7% vs. 3.1%, p = 0.07) and previous rejection events (21.4% vs. 5.3%, p = 0.08). Diffuse glomerular lesions were observed in all TMA cases, with capillary congestion (100 vs. 35.1%, p < 0.01), microthrombi (50% vs. 5.4, p = 0.01), schistocytes (42.8% vs. 7.7%, p = 0.01) and mesangiolysis (85.7% vs. 29.7%, p < 0.01). Positive C4d in de novo TMA cases was similar to TG (71.4% vs. 53.8%, p = ns) but presented arteriolar C4d deposition (35.7 % vs. 8.7%, p = 0.042). Donor -specific antibodies detection was equally found (TG: 41.6%; TMA: 57.1%, p = ns), mainly anti-HLA Class II. In ultrastructural analysis only TG cases presented glomerular basement membrane (GBM) multilayering. Graft loss was similar, but de novo MAT cases had worst first year survival (73.3% vs. 97%, p = 0.013). Conclusion: Both pathologies belong within the spectrum of microcirculatory injury: TG results from subclinical lesion, presenting chronic cyclic accommodation, de novo TMA represents severe form of lytic endothelial lesion
publishDate 2014
dc.date.none.fl_str_mv 2014-09-01
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300005
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692014000300005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
publisher.none.fl_str_mv Sociedade Portuguesa de Nefrologia
dc.source.none.fl_str_mv Portuguese Journal of Nephrology &amp; Hypertension v.28 n.3 2014
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799137279040552960